Literature DB >> 24258155

Boronic acid-modified magnetic materials for antibody purification.

Vijaykumar L Dhadge1, Abid Hussain, Ana M Azevedo, Raquel Aires-Barros, Ana C A Roque.   

Abstract

Aminophenyl boronic acids can form reversible covalent ester interactions with cis-diol-containing molecules, serving as a selective tool for binding glycoproteins as antibody molecules that possess oligosaccharides in both the Fv and Fc regions. In this study, amino phenyl boronic acid (APBA) magnetic particles (MPs) were applied for the magnetic separation of antibody molecules. Iron oxide MPs were firstly coated with dextran to avoid non-specific binding and then with 3-glycidyloxypropyl trimethoxysilane to allow further covalent coupling of APBA (APBA_MP). When contacted with pure protein solutions of human IgG (hIgG) and bovine serum albumin (BSA), APBA_MP bound 170 ± 10 mg hIgG g(-1) MP and eluted 160 ± 5 mg hIgG g(-1) MP, while binding only 15 ± 5 mg BSA g(-1) MP. The affinity constant for the interaction between hIgG and APBA_MP was estimated as 4.9 × 10(5) M(-1) (Ka) with a theoretical maximum capacity of 492 mg hIgG adsorbed g(-1) MP (Qmax), whereas control particles bound a negligible amount of hIgG and presented an estimated theoretical maximum capacity of 3.1 mg hIgG adsorbed g(-1) MP (Qmax). APBA_MPs were also tested for antibody purification directly from CHO cell supernatants. The particles were able to bind 98% of IgG loaded and to recover 95% of pure IgG (purity greater than 98%) at extremely mild conditions.

Entities:  

Keywords:  amino phenyl boronic acid; antibodies; glycosylated proteins; magnetic particles

Mesh:

Substances:

Year:  2013        PMID: 24258155      PMCID: PMC3869159          DOI: 10.1098/rsif.2013.0875

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  16 in total

1.  Potential of boronic acid functionalized magnetic particles in the adsorption of human antibodies under mammalian cell culture conditions.

Authors:  L Borlido; A M Azevedo; A C A Roque; M R Aires-Barros
Journal:  J Chromatogr A       Date:  2011-09-03       Impact factor: 4.759

2.  Facile synthesis of copper(II) immobilized on magnetic mesoporous silica microspheres for selective enrichment of peptides for mass spectrometry analysis.

Authors:  Shasha Liu; Hemei Chen; Xiaohui Lu; Chunhui Deng; Xiangmin Zhang; Pengyuan Yang
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-04       Impact factor: 15.336

Review 3.  Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles.

Authors:  Rui Hao; Ruijun Xing; Zhichuan Xu; Yanglong Hou; Song Gao; Shouheng Sun
Journal:  Adv Mater       Date:  2010-07-06       Impact factor: 30.849

4.  A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.

Authors:  Michael Kuczewski; Emily Schirmer; Blanca Lain; Gregory Zarbis-Papastoitsis
Journal:  Biotechnol J       Date:  2011-01       Impact factor: 4.677

5.  Functionalization of monodisperse magnetic nanoparticles.

Authors:  Marco Lattuada; T Alan Hatton
Journal:  Langmuir       Date:  2007-02-13       Impact factor: 3.882

6.  Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery.

Authors:  Jaeyun Kim; Hoe Suk Kim; Nohyun Lee; Taeho Kim; Hyoungsu Kim; Taekyung Yu; In Chan Song; Woo Kyung Moon; Taeghwan Hyeon
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

7.  One-pot synthesis of hollow/porous Mn-based nanoparticles via a controlled ion transfer process.

Authors:  Rui Hao; Jing Yu; Yanglong Hou; Shouheng Sun
Journal:  Chem Commun (Camb)       Date:  2011-07-04       Impact factor: 6.222

8.  Dextran-coated magnetic supports modified with a biomimetic ligand for IgG purification.

Authors:  Sara D F Santana; Vijaykumar L Dhadge; Ana C A Roque
Journal:  ACS Appl Mater Interfaces       Date:  2012-11-06       Impact factor: 9.229

9.  Fe3O4 nanostructures: synthesis, growth mechanism, properties and applications.

Authors:  Ce Yang; Jiajia Wu; Yanglong Hou
Journal:  Chem Commun (Camb)       Date:  2011-03-07       Impact factor: 6.222

10.  Alizarin Red S. as a general optical reporter for studying the binding of boronic acids with carbohydrates.

Authors:  G Springsteen; B Wang
Journal:  Chem Commun (Camb)       Date:  2001-09-07       Impact factor: 6.222

View more
  5 in total

1.  An extracellular polymer at the interface of magnetic bioseparations.

Authors:  Vijaykumar L Dhadge; Patricia I Morgado; Filomena Freitas; Maria A Reis; Ana Azevedo; Raquel Aires-Barros; A Cecilia A Roque
Journal:  J R Soc Interface       Date:  2014-11-06       Impact factor: 4.118

2.  Highly efficient antibody purification with controlled orientation of protein A on magnetic nanoparticles.

Authors:  Sunghyun Kim; Daekyung Sung; Jeong Ho Chang
Journal:  Medchemcomm       Date:  2017-11-02       Impact factor: 3.597

3.  Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap.

Authors:  Yacine Bounab; Klaus Eyer; Sophie Dixneuf; Magda Rybczynska; Cécile Chauvel; Maxime Mistretta; Trang Tran; Nathan Aymerich; Guilhem Chenon; Jean-François Llitjos; Fabienne Venet; Guillaume Monneret; Iain A Gillespie; Pierre Cortez; Virginie Moucadel; Alexandre Pachot; Alain Troesch; Philippe Leissner; Julien Textoris; Jérôme Bibette; Cyril Guyard; Jean Baudry; Andrew D Griffiths; Christophe Védrine
Journal:  Nat Protoc       Date:  2020-08-12       Impact factor: 13.491

Review 4.  An overview on the investigation of nanomaterials' effect on plasma components: immunoglobulins and coagulation factor VIII, 2010-2020 review.

Authors:  Tahereh Zadeh Mehrizi; Kamran Mousavi Hosseini
Journal:  Nanoscale Adv       Date:  2021-05-18

5.  Self-grafting copper oxide nanoparticles show a strong enhancement of their anti-algal and anti-yeast action.

Authors:  Ahmed F Halbus; Tommy S Horozov; Vesselin N Paunov
Journal:  Nanoscale Adv       Date:  2019-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.